Journal of the American College of Cardiology
Clinical research: clinical trial
Anemia predicts mortality in severe heart failureThe prospective randomized amlodipine survival evaluation (PRAISE)
Dariush Mozaffarian, Regina Nye and Wayne C Levy
Table 3
Table 3
Total Mortality According to Quintiles of Hematocrit Among Men and Women
First | Second | Third | Fourth | Fifth | |
---|---|---|---|---|---|
Men (n) | >173 | 172 | 176 | 167 | >171 |
Hematocrit (%) | <38.2 | 38.2–41.3 | 41.4–43.7 | 43.8–46.8 | >46.8 |
Deaths per 100 person-years | >45 | 34 | 25 | 24 | 27 |
Unadjusted HR (95% CI) | 1.71 (1.23–2.38) | 1.28 (0.91–1.81) | 0.95 (0.66–1.36) | 0.90 (0.62–1.30) | 1.0 (referent) |
Adjusted HR*(95% CI) | 1.57 (1.09–2.25) | 1.36 (0.95–0.96) | 1.09 (0.75–1.59) | 0.95 (0.65–1.40) | 1.0 (referent) |
Women (n) | 55 | 55 | 54 | 54 | 53 |
Hematocrit (%) | <36.8 | 36.8–38.7 | 38.8–40.9 | 41.0–43.7 | >43.7 |
Deaths per 100 person-years | 36 | 21 | 15 | 30 | 23 |
Unadjusted HR (95% CI) | 1.50 (0.80–2.83) | 0.90 (0.44–1.82) | 0.64 (0.31–1.34) | 1.25 (0.65–2.40) | 1.0 (referent) |
Adjusted HR*(95% CI) | 1.62 (0.83–3.14) | 1.10 (0.53–2.30) | 0.64 (0.30–1.35) | 1.76 (0.88–3.50) | 1.0 (referent) |
Abbreviation as in Table 2.
↵* See Table 2footnote.
Advertisement